Predicting the costs of managing patients with chronic obstructive pulmonary disease.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Respiratory Medicine

• Publication date

  2005-10-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/J.RMED.2005.03.001PMID 16140232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Economic Burden of Chronic Obstructive Pulmonary Disease

  2012cited by this paper
• [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].

  2004cited by this paper
• The GOLD classification has not advanced understanding of COPD.

  2004cited by this paper
• The burden of COPD in the U.S.A.: results from the Confronting COPD survey.

  2003cited by this paper
• Inhaled Corticosteroids With/Without Long-Acting β-Agonists Reduce the Risk of Rehospitalization and Death in COPD Patients

  2003cited by this paper
• Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

  2003cited by this paper
• Economic analysis of the Confronting COPD survey: an overview of results.

  2003cited by this paper
• Global initiative for chronic obstructive lung disease.

  2002cited by this paper
• Community-acquired pneumonia guidelines: much guidance, but not much evidence

  2002cited by this paper
• The costs of exacerbations in chronic obstructive pulmonary disease (COPD).

  2002cited by this paper
• Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

  2002cited by this paper
• Decision-making by healthcare payers.

  2002cited by this paper
• Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice

  2002cited by this paper
• The economic impact of chronic obstructive pulmonary disease

  2002cited by this paper
• Hospitalizations and mortality in the Lung Health Study.

  2002cited by this paper
• Obtaining evidence for use by healthcare payers on the success of chronic obstructive pulmonary disease management.

  2002cited by this paper
• Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD.

  2002cited by this paper
• The health impact of undiagnosed airflow obstruction in a national sample of United States adults.

  2001cited by this paper
• Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease.

  2001cited by this paper
• Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

  2000cited by this paper
• Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.

  2000cited by this paper
• Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

  2000cited by this paper
• The economic burden of COPD.

  2000cited by this paper
• Pharmacoeconomic evaluation of COPD.

  2000cited by this paper
• The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.

  2000cited by this paper
• Treatment cost of acute exacerbations of chronic bronchitis.

  1999cited by this paper
• Methods for analyzing health care utilization and costs.

  1999cited by this paper
• Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

  1997cited by this paper
• Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

  1996cited by this paper
• The Global Burden of Disease

  1996cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper

• Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease

  2023cites this paper
• ANALYSIS OF TOTAL, DIRECT AND INDIRECT COST OUTLIERS IN A POLISH SPECIALIST HOSPITAL

  2020cites this paper
• 188 Identification of patients with potential palliative care needs: a systematic review of screening tools in primary care

  2020cites this paper
• Characteristics of long-term home oxygen therapy users in the municipality of Curitiba, Brazil

  2019cites this paper
• Patient predictors of individual cost of integrated treatment program for alcohol problems at community hospitals in southern Thailand.

  2019cites this paper
• Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal

  2019cites this paper
• Mobile health applications in self-management of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of their efficacy

  2018cites this paper
• Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program

  2017cites this paper
• Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

  2017cites this paper
• Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

  2017cites this paper
• Analysis of high cost outliers in a Polish reference hospital

  2017cites this paper
• Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD

  2016cites this paper
• Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?

  2016cites this paper
• Spirometry, the St. George's Respiratory Questionnaire, and other clinical measures as predictors of medical costs and COPD exacerbation events in a prospective cohort

  2015cites this paper
• Respiratory Diseases and Health Disorders Related to Indoor and Outdoor Air Pollution

  2015cites this paper
• Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol

  2015cites this paper
• Hospitalization Due to Co-Morbid Conditions is the Main Cost Driver Among Subjects With COPD–A Report From the Population-Based OLIN COPD Study

  2015cites this paper
• Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea

  2014influential citation
• Management of Asthma and Chronic Obstructive Pulmonary Disease with Combination Inhaled Corticosteroids and Long-Acting β-Agonists: A Review of Comparative Effectiveness Research

  2014cites this paper
• Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD

  2013cites this paper
• Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary Disease

  2013cites this paper
• Original article Healthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care population

  2013cites this paper
• Healthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care population

  2013cites this paper
• A New Method for Examining the Cost Savings of Reducing COPD Exacerbations

  2012cites this paper
• Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor

  2012cites this paper
• New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses

  2012cites this paper
• Strategic Intelligence Monitor on Personal Health Systems phase 2 (SIMPHS 2) Impact Assessment Final Report

  2012cites this paper
• Clinical and Economic Burden of Depression/Anxiety in Chronic Obstructive Pulmonary Disease Patients within a Managed Care Population

  2011cites this paper
• Can outpatient pharmacy data identify persons with undiagnosed COPD?

  2010cites this paper
• Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease.

  2010cites this paper
• Pharmacoéconomie pour le pneumologue

  2010cites this paper
• Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort

  2009cites this paper
• Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score.

  2009cites this paper
• Aspects of healthcare utilisation in self‐reported obstructive lung disease

  2009cites this paper
• Therapeutic strategies in acute exacerbations in COPD

  2009influential citation
• ACUTE EXACERBATIONS IN COPD

  2009influential citation
• Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan

  2008cites this paper
• Validation of symptom‐based COPD questionnaires in Japanese subjects

  2008cites this paper
• Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications

  2008cites this paper
• FACTORS AFFECTING COPD-RELATED COSTS: A MULTIVARIATE ANALYSIS OF A SWEDISH COPD COHORT

  2008cites this paper
• The direct medical costs of undiagnosed chronic obstructive pulmonary disease.

  2008cites this paper
• Estudio piloto: costos directos atribuibles al tabaquismo en dos hospitales de Santiago

  2008cites this paper
• One hundred years of respiratory medicine chronic obstructive pulmonary disease (COPD)—Republished article

  2008cites this paper
• A Comparison of Health-Care Costs in Patients With Chronic Obstructive Pulmonary Disease Using Lightweight Portable Oxygen Systems Versus Traditional Compressed-Oxygen Systems

  2008cites this paper
• Determinants and predictors of the cost of COPD in primary care: A Spanish perspective

  2008cites this paper
• Models of chronic disease management in primary care for patients with mild‐to‐moderate asthma or COPD: a narrative review

  2008cites this paper
• Economics of COPD: literature review and experiences from field work

  2008cites this paper
• Efficacy of a cell phone-based exercise programme for COPD

  2008cites this paper
• [Pilot study: tobacco-attributable direct costs in two hospitals in Santiago, Chile].

  2008cites this paper
• Abstract Number: 007-0252 Abstract Title: APPLICATIONS OF COST MINIMIZATION IN A TEACHING HOSPITAL

  2007cites this paper
• Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach.

  2007cites this paper
• Predictors of rehospitalization and death after a severe exacerbation of COPD.

  2007cites this paper
• One hundred years of chronic obstructive pulmonary disease (COPD).

  2007cites this paper
• Modifying the clinical course of COPD

  2006cites this paper
• Outcomes and Humanistic Issues Related to Treatment of Acute Bronchospasm

  2006cites this paper
• An Algorithm for the Identification of Undiagnosed COPD Cases Using Administrative Claims Data

  2006cites this paper
• Assessment of the Economic Burden of COPD in the U.S.: A Review and Synthesis of the Literature

  2006cites this paper
• An Algorithm for the Identification of Undiagnosed COPD Cases Using Administrative Claims Data

  2006cites this paper
• Aspects médico-économiques de la pneumologie

  2004cites this paper
• International Journal of Copd Dovepress Economic Burden of Chronic Bronchitis in the United States: a Retrospective Case-control Study

  year unknowncites this paper
• International Journal of Copd Dovepress Comparative Cost-effectiveness of a Fluticasone- Propionate/salmeterol Combination versus Anticholinergics as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease

  year unknowncites this paper